Registration - In-house Corporation

Teva Canada Limited / Teva Canada Limitee / Fabien Paquette, General Manager

Registration Information

In-house Corporation name: Teva Canada Limited / Teva Canada Limitee
Previous in-house corporation names
Responsible Officer Name: Fabien Paquette, General Manager
Responsible Officer Change History
Initial registration start date: 2009-01-13
Registration status: Active
Registration Number: 958840-235321

Associated Communications

Total Number of Communication Reports: 100

Monthly communication reports in the last 6 months: 0

Version 1 of 40 (2009-01-13 to 2009-09-03)

Registration versions:

Version 1 of 40 (2009-01-13 to 2009-09-03)

Lobbying Information

Subject Matters

Health
Industry
Intellectual Property
Science and Technology

Subject Matter Details

Policies or Program

Health Canada regarding the development and implementation of an approval pathway for Subsequent Entry Biologics (SEBs).
Health Canada regarding the modernization of the Food and Drug Act (formerly Bill C-51) with respect to the development and implementation of a Progressive Licensing Framework for pharmaceuticals
Industry Canada's Science and Technology strategy regarding the need for a balanced Intelectual Property regime and the important role competition plays in encouraging innovation (Mobilizing Science and Technology to Canada's Advantage -- 2007)

Regulation

Industry Canada regarding the need to restore balance to the Patented Medicines (Notice of Compliance) Regulations with respect to pharmaceuticals and address operational concerns including: lack of finality to proceedings under the Regulations and lack of disincentives to discourage abuse of the Regulations.

Communication Techniques

Written communication
Oral communication

Government Institutions

Finance Canada (FIN)
Health Canada (HC)
House of Commons
Industry Canada
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Senate of Canada

In-house Corporation Details

Description of activities

PHARMACEUTICAL COMPANY Manufacturing and distribution of Generic Prescription Pharmaceuticals Products

Responsible officer name and position during the period of this registration

Barry Fishman, president & Chief Executive Officer

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
30 novopharm court
toronto, ON M1B 2K9
Canada

Telephone number: 416-291-8888

Parent Company Information

Teva
- basel
  Petach Tikva 49131
  Israel

Subsidiary Beneficiary Information

Teva Novopharm does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

No lobbyists added

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Terry Creighton, VP Government Affairs | No public offices held

Teva Canada Limited/Teva Canada Limitee

The following names have been used on or after July 2, 2008

Name	From	To
Teva Canada Limited/Teva Canada Limitee	2010-11-15	current
Teva Novopharm	2009-01-13	2009-09-03

Teva Canada Limited / Teva Canada Limitee

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
Fabien Paquette	2024-07-29	Current
Michael Sine	2022-07-26	2024-07-29
Christine Poulin	2018-04-01	2022-07-26
Douglas Sommerville	2014-01-01	2018-04-01
Barry Fishman	2009-01-13	2014-01-01

Date Modified:: 2026-05-11

Search and menus

Language selection

Registration - In-house Corporation

Teva Canada Limited / Teva Canada Limitee / Fabien Paquette, General Manager

Registration Information

Associated Communications

Version 1 of 40 (2009-01-13 to 2009-09-03)

Version 1 of 40 (2009-01-13 to 2009-09-03)

Subject Matters

Subject Matter Details

Policies or Program

Regulation

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties